- Home
- PMCB vs TRIB Comparison
PMCB vs TRIB Comparison
Compare PMCB & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- TRIB
- Stock Information
- Founded
- PMCB 1996
- TRIB 1992
- Country
- PMCB United States
- TRIB Ireland
- Employees
- PMCB N/A
- TRIB N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PMCB Health Care
- TRIB Health Care
- Exchange
- PMCB Nasdaq
- TRIB Nasdaq
- Market Cap
- PMCB 11.4M
- TRIB 10.7M
- IPO Year
- PMCB N/A
- TRIB N/A
- Fundamental
- Price
- PMCB $1.06
- TRIB $0.75
- Analyst Decision
- PMCB
- TRIB
- Analyst Count
- PMCB 0
- TRIB 0
- Target Price
- PMCB N/A
- TRIB N/A
- AVG Volume (30 Days)
- PMCB 11.3K
- TRIB 59.6K
- Earning Date
- PMCB 03-17-2025
- TRIB 05-22-2025
- Dividend Yield
- PMCB N/A
- TRIB N/A
- EPS Growth
- PMCB N/A
- TRIB N/A
- EPS
- PMCB 1.29
- TRIB N/A
- Revenue
- PMCB N/A
- TRIB $59,126,000.00
- Revenue This Year
- PMCB N/A
- TRIB $11.63
- Revenue Next Year
- PMCB N/A
- TRIB $10.13
- P/E Ratio
- PMCB $0.85
- TRIB N/A
- Revenue Growth
- PMCB N/A
- TRIB N/A
- 52 Week Low
- PMCB $1.03
- TRIB $0.48
- 52 Week High
- PMCB $2.42
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- PMCB 36.21
- TRIB 61.46
- Support Level
- PMCB $1.08
- TRIB $0.72
- Resistance Level
- PMCB $1.39
- TRIB $0.84
- Average True Range (ATR)
- PMCB 0.10
- TRIB 0.06
- MACD
- PMCB 0.00
- TRIB 0.01
- Stochastic Oscillator
- PMCB 0.00
- TRIB 77.11
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.